Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Treatment

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   

Living with dementia

irritability1 - dimebon1 - heart attack2 - senility1 - decline of memory1 - brain functions in patients1 - dementia risk4 - korsakoff syndrome3 - alzheimer type2 - neurodegenerative disorder4 - journal of the american geriatrics society1 - effective aging1 - reversible dementia syndrome1 - moderate severe decline1 - impaired-memory disorder1 - national alzheimer's project act1 - normal aging1 - ptau1 - people with parkinsons1 - hay fever1 - apolipoprotein e41 - bmi2 - csf1 - mayo clinic1 - retinopathy1 - aids related dementia1 - parkinson's disease protein1 - gray matter1 - parkinson’s disease2 - treatments for alzheimer's1 -